Our biopharmaceutical services begin with our capability to understand the composition of your drug product or substance. At the heart of our services are method development and validation of QC and stability-indicating methods under cGMP, according to ICH guidelines.
Milestone-based projects are planned to fit your drug development program. Our proven expertise has been applied to complex analytical challenges such as biosimilars (follow on biologics), PEGylation, glycans, post-translational modifications and excipients such as Tween 80.
Solvias has an excellent reputation with global pharmaceutical corporations for the characterization and QC analysis of monoclonal antibodies and other protein biologics. However, small biotechnology companies can gain access to the standards established by market-leading biopharmaceutical companies.